- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02212158
Diabetes Intervention Program for Adolescents With Persistent High HA1c
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Basic Design:
This study will pilot a group therapy intervention for adolescents seen in the diabetes clinic who have had elevated HA1c's for at least 3 months. This group will be offered in fall of 2014. Group therapy sessions will include 8 teen sessions that cover the following topics: acceptance of diabetes, family issues, division of diabetes management, communication and facilitating motivation and skill development to improve diabetes care. Motivational interviewing and cognitive behavioral techniques will be the therapeutic modalities used in sessions. Parents will be involved in 3 therapy sessions that cover topics regarding family functioning, division of responsibility and parenting strategies. Participants will complete questionnaires measuring self-efficacy, family support, quality of life, readiness to change and symptoms of depression. Questionnaires will be administered at an initial assessment prior to participation in the group, at completion of the 8 week program, at a follow-up visit 2 months following the completion of the group and 1 year post-intervention. Questionnaires will take approximately 45 minutes to complete. HA1c levels will be evaluated for participants every 3 months as per regular clinic care. This intervention program will be offered to teens upon an elevated HA1c result.
Primary Outcomes:
HA1c levels will be tested every three months as per regular clinic care. Basic demographic information will be obtained from participants during the initial assessment for the group (age, family size, and date of diagnosis of diabetes).
Secondary Outcomes:
Psychosocial functioning will be evaluated pre- and post-intervention by having participants and their parents fill out the following questionnaires: Self-efficacy for Diabetes Scale (SED); Diabetes Quality of Life for Youths; Diabetes Family Behavior Scale; Beck Depression Inventory for Youth (BDI-Y); Diabetes Management Questionnaire; Child Behavior Checklist (Parent form); Low Blood Sugar Survey, and Children's Hope Scale.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 0Z9
- Diabetes Resource for Children and Adolescence
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The therapy group will be composed of teens that currently have a documented history of elevated HA1c's that have persisted for at least 3 months
- Potential candidates for the group will be recruited from all the physician's caseloads in the clinic.
Exclusion Criteria:
- Patients with Type II diabetes
- Those who are medically unstable due to other medical conditions
- Those who refuse to participate will not be included in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: motivational interviewing group
Motivational Group Intervention: Group therapy sessions will include 8 teen sessions that cover the following topics: acceptance of diabetes, family issues, division of diabetes management, communication and facilitating motivation and skill development to improve diabetes care. Motivational interviewing and cognitive behavioral techniques will be the therapeutic modalities used in sessions. Parents will be involved in 3 therapy sessions that cover topics regarding family functioning, division of responsibility and parenting strategies. |
Group therapy sessions will include 8 teen sessions that cover the following topics: acceptance of diabetes, family issues, division of diabetes management, communication and facilitating motivation and skill development to improve diabetes care.
Motivational interviewing and cognitive behavioral techniques will be the therapeutic modalities used in sessions.
Parents will be involved in 3 therapy sessions that cover topics regarding family functioning, division of responsibility and parenting strategies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline HA1c at 6 months post baseline
Time Frame: Baseline, 6-months post baseline
|
Baseline, 6-months post baseline
|
|
Change from baseline HA1c at 3 months post baseline
Time Frame: Baseline, 3-months post baseline
|
Baseline, 3-months post baseline
|
|
Change from Baseline HA1c at 9 months post baseline
Time Frame: Baseline, 9-months post baseline
|
Baseline, 9-months post baseline
|
|
Change in Baseline HA1c at 12 months post baseline
Time Frame: Baseline, 12-months post baseline
|
Baseline, 12-months post baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in Self-efficacy for Diabetes scale (SED) at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Self-efficacy for Diabetes scale (SED) at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Self-efficacy for Diabetes scale (SED) at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Diabetes Family Behavior Scale at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Diabetes Family Behavior Scale at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Diabetes Family Behavior Scale at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Beck Depression Inventory for Youth (BDI-Y) at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Beck Depression Inventory for Youth (BDI-Y) at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Beck Depression Inventory for Youth (BDI-Y) at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Diabetes Quality of LIfe for Youth at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Diabetes Quality of LIfe for Youth at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Diabetes Quality of LIfe for Youth at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Diabetes Management Questionnaire at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Diabetes Management Questionnaire at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Diabetes Management Questionnaire at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Child Behavior Checklist (Parent form) at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Child Behavior Checklist (Parent form) at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Child Behavior Checklist (Parent form) at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Low Blood Sugar Survey at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Low Blood Sugar Survey at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Low Blood Sugar Survey at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
|
Change from baseline in Children's Hope Scale at 8 weeks
Time Frame: baseline, 8 weeks
|
baseline, 8 weeks
|
|
Change from baseline in Children's Hope Scale at 16 weeks
Time Frame: baseline, 16 weeks
|
baseline, 16 weeks
|
|
Change from baseline in Children's Hope Scale at 60 weeks
Time Frame: baseline, 60 weeks
|
baseline, 60 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Heather MacKenzie, PhD, University of Manitoba
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2014:206
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 1
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Abdullah KarsNot yet recruitingType 1 Diabetes Mellitus | Autoimmune Diabetes | Type 1 Diabetes Mellitus (T1DM)Turkey (Türkiye)
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
Clinical Trials on motivational interviewing group
-
Qazvin University Of Medical SciencesCompletedObesity, AdolescentIran, Islamic Republic of
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiNot yet recruiting
-
Chinese University of Hong KongThe University of Hong KongCompleted
-
Saglik Bilimleri UniversitesiRecruiting
-
Kahramanmaraş İstiklal UniversityRecruitingCOPD | Motivational InterviewingTurkey
-
National Yang Ming UniversityTaipei Veterans General Hospital, TaiwanCompletedMedication Adherence | Motivational Interviewing | Schizophrenia Spectrum DisorderTaiwan
-
The Hospital for Sick ChildrenCompleted
-
National Institute of Diabetes and Digestive and...CompletedObesity | Diabetes Mellitus, Type 2United States
-
University Hospital, MontpellierRecruitingAddiction | Alcohol Use Disorder | Relapse | Alcohol Withdrawal | Motivational InterviewsFrance